Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeo Matsuda

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Nature Biotechnology|May 23, 2018
Reversal of siRNA-mediated gene silencing in vivoIvan Zlatev, Adam Castoreno, Christopher R Brown, et al.
Nucleic Acids Research|July 16, 2021
Chirality matters: stereo-defined phosphorothioate linkages at the termini of small interfering RNAs improve pharmacology in vivoHartmut Jahns, Nate Taneja, Jennifer L S Willoughby, et al.
Nucleic Acids Research|February 12, 2021
siRNAs containing 2'-fluorinated Northern-methanocarbacyclic (2'-F-NMC) nucleotides: in vitro and in vivo RNAi activity and inability of mitochondrial polymerases to incorporate 2'-F-NMC NTPsMasaaki Akabane-Nakata, Namrata D Erande, Pawan Kumar, et al.
ACS Chemical Biology|March 3, 2015
siRNA conjugates carrying sequentially assembled trivalent N-acetylgalactosamine linked through nucleosides elicit robust gene silencing in vivo in hepatocytesShigeo Matsuda, Kristofer Keiser, Jayaprakash K Nair, et al.
Angewandte Chemie (International Ed. in English)|July 12, 2012
Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivoMuthusamy Jayaraman, Steven M Ansell, Barbara L Mui, et al.
Journal of the American Chemical Society|September 23, 2017
4'-C-Methoxy-2'-deoxy-2'-fluoro Modified Ribonucleotides Improve Metabolic Stability and Elicit Efficient RNAi-Mediated Gene SilencingElise Malek-Adamian, Dale C Guenther, Shigeo Matsuda, et al.
Nucleic Acids Research|August 19, 2020
Investigating the pharmacodynamic durability of GalNAc-siRNA conjugatesChristopher R Brown, Swati Gupta, June Qin, et al.
Journal of Medicinal Chemistry|February 9, 2023
Metabolically Stable Anomeric Linkages Containing GalNAc-siRNA Conjugates: An Interplay among ASGPR, Glycosidase, and RISC PathwaysPachamuthu Kandasamy, Shohei Mori, Shigeo Matsuda, et al.
Journal of the American Chemical Society|August 28, 2023
Shorter Is Better: The α-(l)-Threofuranosyl Nucleic Acid Modification Improves Stability, Potency, Safety, and Ago2 Binding and Mitigates Off-Target Effects of Small Interfering RNAsShigeo Matsuda, Saikat Bala, Jen-Yu Liao, et al.
Nucleic Acids Research|May 14, 2024
Evaluating the oral delivery of GalNAc-conjugated siRNAs in rodents and non-human primatesMikyung Yu, June Qin, Xiumin Liu, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Nature Biotechnology|May 23, 2018
Reversal of siRNA-mediated gene silencing in vivoIvan Zlatev, Adam Castoreno, Christopher R Brown, et al.
Nucleic Acids Research|July 16, 2021
Chirality matters: stereo-defined phosphorothioate linkages at the termini of small interfering RNAs improve pharmacology in vivoHartmut Jahns, Nate Taneja, Jennifer L S Willoughby, et al.
Nucleic Acids Research|February 12, 2021
siRNAs containing 2'-fluorinated Northern-methanocarbacyclic (2'-F-NMC) nucleotides: in vitro and in vivo RNAi activity and inability of mitochondrial polymerases to incorporate 2'-F-NMC NTPsMasaaki Akabane-Nakata, Namrata D Erande, Pawan Kumar, et al.
ACS Chemical Biology|March 3, 2015
siRNA conjugates carrying sequentially assembled trivalent N-acetylgalactosamine linked through nucleosides elicit robust gene silencing in vivo in hepatocytesShigeo Matsuda, Kristofer Keiser, Jayaprakash K Nair, et al.
Angewandte Chemie (International Ed. in English)|July 12, 2012
Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivoMuthusamy Jayaraman, Steven M Ansell, Barbara L Mui, et al.
Journal of the American Chemical Society|September 23, 2017
4'-C-Methoxy-2'-deoxy-2'-fluoro Modified Ribonucleotides Improve Metabolic Stability and Elicit Efficient RNAi-Mediated Gene SilencingElise Malek-Adamian, Dale C Guenther, Shigeo Matsuda, et al.
Nucleic Acids Research|August 19, 2020
Investigating the pharmacodynamic durability of GalNAc-siRNA conjugatesChristopher R Brown, Swati Gupta, June Qin, et al.
Journal of Medicinal Chemistry|February 9, 2023
Metabolically Stable Anomeric Linkages Containing GalNAc-siRNA Conjugates: An Interplay among ASGPR, Glycosidase, and RISC PathwaysPachamuthu Kandasamy, Shohei Mori, Shigeo Matsuda, et al.
Journal of the American Chemical Society|August 28, 2023
Shorter Is Better: The α-(l)-Threofuranosyl Nucleic Acid Modification Improves Stability, Potency, Safety, and Ago2 Binding and Mitigates Off-Target Effects of Small Interfering RNAsShigeo Matsuda, Saikat Bala, Jen-Yu Liao, et al.
Nucleic Acids Research|May 14, 2024
Evaluating the oral delivery of GalNAc-conjugated siRNAs in rodents and non-human primatesMikyung Yu, June Qin, Xiumin Liu, et al.
Pageof 5